title: BORIS (CTCFL) is not expressed in most human breast cell lines and high grade breast carcinomas.
authors.affiliation: Life Sciences Division, Lawrence Berkeley National Laboratory, Berkeley, California, United States of America.
authors.forename: William C
authors.initials: WC
authors.lastname: Hines
authors.forename: Alexey V
authors.initials: AV
authors.lastname: Bazarov
authors.forename: Rituparna
authors.initials: R
authors.lastname: Mukhopadhyay
authors.forename: Paul
authors.initials: P
authors.lastname: Yaswen
mesh_terms: D017398:Alternative Splicing; D001374:Azacitidine / Q000031:analogs & derivatives / Q000494:pharmacology; D001943:Breast Neoplasms / Q000378:metabolism*; D000076246:CCCTC-Binding Factor; D002277:Carcinoma / Q000378:metabolism*; D045744:Cell Line, Tumor; D004268:DNA-Binding Proteins / Q000096:biosynthesis*; D000077209:Decitabine; D005091:Exons; D005347:Fibroblasts / Q000378:metabolism; D015972:Gene Expression Regulation, Neoplastic; D006801:Humans; D016133:Polymerase Chain Reaction / Q000379:methods; D012333:RNA, Messenger / Q000378:metabolism; D012097:Repressor Proteins / Q000378:metabolism; D020133:Reverse Transcriptase Polymerase Chain Reaction; D014018:Tissue Distribution
chemical_list: D000076246:CCCTC-Binding Factor; C000619697:CTCF protein, human; C456540:CTCFL protein, human; D004268:DNA-Binding Proteins; D012333:RNA, Messenger; D012097:Repressor Proteins; D000077209:Decitabine; D001374:Azacitidine